X0508 4 2026-02-16 0 0001743881 BridgeBio Pharma, Inc. BBIO 0002058197 Apuli Maricel C/O BRIDGEBIO PHARMA, INC. 3160 PORTER DR., SUITE 250 PALO ALTO CA 94304 0 1 0 0 Chief Accounting Officer 1 Common Stock 2026-02-16 4 F 0 4349 75.25 D 124455 D Common Stock 2026-02-17 4 S 0 510 74.31 D 123945 D Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 8,377 shares of Common Stock underlying the Reporting Person's RSUs. Includes 510 shares of the Issuer's Common Stock acquired by the Reporting Person on February 13, 2026 pursuant to the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3. This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on September 8, 2025. /s/ Maricel Apuli 2026-02-18